Three Powerful Markers Your CMP Leaves Out — And Why Each One Matters

By Michael Rutherford

A comprehensive metabolic panel returns fourteen markers — and three of the most informative markers in all of blood chemistry are not among them. Each has to be ordered separately, which is precisely why they go unused. Most practitioners read only what the default panel hands them.

Why the Default Panel Quietly Limits You

The comprehensive metabolic panel is a workhorse, and it earns its place. But it was designed for conventional screening — flagging frank disease against population reference ranges — not for the early, pattern-based assessment that functional practice depends on. It gives you glucose, calcium, the electrolytes, kidney markers, the standard liver enzymes, total protein, albumin, and bilirubin. Then it stops.

Three markers that each open an entire dimension of assessment sit just outside that default set, available the moment you check an additional box on the requisition. They aren't exotic or expensive. They're simply not included by default — and that single fact is why so much useful information goes uncollected. Each of the three opens a system the CMP cannot see: oxidative stress and detoxification capacity, early metabolic dysfunction, and cellular integrity. Read together, they also form patterns that none of them reveals alone.

The Oxidative Stress Sentinel Most Practitioners Never Order

Gamma-glutamyl transferase is classified as a liver enzyme, and most practitioners file it there and move on. But its real diagnostic power is upstream of liver damage entirely. GGT is the most sensitive routinely available marker of oxidative stress and glutathione turnover — it sits at the cell membrane participating in the recovery of glutathione, the body's master antioxidant, and its serum activity rises as the system works harder to maintain redox balance.¹

This is why GGT often climbs in response to toxin exposure, alcohol, and medication burden long before ALT or AST register anything at all. An elevated GGT alongside otherwise quiet liver enzymes is a signature of systemic oxidative stress rather than structural hepatic injury. And the marker carries weight well beyond the liver: meta-analysis shows GGT independently predicts both cardiovascular and all-cause mortality, and it serves as an early signal for atherosclerosis, arterial stiffness, and metabolic disease.^2,3 A GGT that is technically "normal" but climbing across serial draws is one of the earliest warnings available that antioxidant reserves are being drawn down faster than they're replenished.

Because GGT rewards a deeper treatment than space allows here, our full breakdown of how medications and exposures distort lab interpretation covers many of the drivers that push it upward.

The "Gout Test" That's Really a Metabolic Early-Warning

Uric acid suffers from a branding problem. Practitioners see it, think "gout," and dismiss it unless the client has joint pain. In doing so they overlook one of the earliest and most actionable signals of metabolic dysfunction available on a blood panel.

The connection runs through fructose. Unlike glucose, fructose is metabolized by fructokinase in a reaction that has no negative feedback control — it consumes ATP rapidly, depletes intracellular phosphate, and generates uric acid as a direct byproduct.⁴ That uric acid is not inert. It reduces the bioavailability of endothelial nitric oxide, a key mediator of insulin's action that normally increases blood flow to skeletal muscle and enhances glucose uptake. Lower nitric oxide means impaired glucose disposal — in other words, insulin resistance.⁵ Elevated uric acid also generates mitochondrial oxidative stress that promotes fat accumulation independent of caloric intake, and exerts pro-inflammatory effects on adipose tissue.⁶

The clinical consequence is that a serum uric acid drifting toward the top of its range — in a client whose fasting glucose still looks pristine — is an early flag for fructose load and developing insulin resistance. Notably, the threshold above which uric acid begins independently predicting hyperinsulinemia sits right around 5.5 mg/dL, which is why the functional ceiling lands meaningfully below the conventional one.⁵ Uric acid belongs in your Tier 1 metabolic read, not quarantined as a rheumatology test.

The Marker That Says Something Is Breaking Down — Somewhere

Lactate dehydrogenase is the marker practitioners most often skip, because its greatest strength reads at first like a weakness: it is non-specific. LDH is a cytoplasmic enzyme present in nearly every tissue in the body — heart, liver, muscle, kidney, lung, and red blood cells — so total serum LDH reflects cellular turnover and tissue damage across the whole system rather than the function of any one organ.⁷

That generality is exactly what makes it valuable as a screening flag. An unexplained LDH elevation doesn't tell you where, but it reliably tells you that something is breaking down — and that is information worth having before you've decided where to look. The marker's highest-value functional application is the detection of hemolysis. When red cells rupture, they release their LDH into serum, and the classic diagnostic triad of elevated LDH, decreased haptoglobin, and elevated indirect bilirubin distinguishes hemolysis from the other causes of an LDH rise.⁸

This matters enormously for how you read the rest of the panel. Undetected hemolysis distorts ferritin, iron studies, and bilirubin, and it can send a practitioner chasing an iron or liver story that doesn't exist. Catching the hemolysis first reframes everything downstream — which is why LDH deserves a place alongside the iron panel interpretation rather than in isolation. Beyond hemolysis, LDH reflects anaerobic metabolism and general tissue stress. A markedly elevated, unexplained LDH is a marker to investigate thoroughly and, when significant or persistent, to refer.

The Pattern That Only Appears When You Order All Three

The strongest argument for these markers isn't what each reveals individually — it's what they reveal together. When GGT, uric acid, and bilirubin all rise in concert, frequently accompanied by fatigue and dyslipidemia, they form a recognizable toxicity profile that points toward mold and mycotoxin exposure, heavy metals, or broader environmental burden. No single one of those three markers makes that case. The pattern across them does.

And here is the quiet problem: a CMP gives you exactly one of those three. Without GGT and uric acid added to the order, the pattern can never assemble — you'd be reading a single elevated bilirubin and seeing nothing. This is the recurring theme of functional blood chemistry done well. The dysfunction lives in the relationships between markers, and you cannot read a relationship when half the markers were never collected. For the broader framework, our guide to pattern recognition as a clinical discipline develops this idea in depth.

The Practical Takeaway

You don't need to order every marker in existence on every client. But adding GGT, uric acid, and LDH to an initial comprehensive workup turns a conventional CMP into something substantially more revealing — oxidative stress and detox capacity, early metabolic dysfunction, and cellular integrity, captured in three inexpensive additions. They earn their place especially when fatigue, suspected toxic burden, unexplained anemia, or stubborn metabolic patterns are part of the picture. The information was always available. It simply wasn't on the default list — and recognizing that is the difference between reading the panel you were handed and reading the panel your client actually needs.

Frequently Asked Questions

Are GGT, uric acid, and LDH genuinely absent from a standard CMP?

Yes. A standard comprehensive metabolic panel comprises fourteen markers: glucose, calcium, sodium, potassium, CO2, chloride, BUN, creatinine, total protein, albumin, ALP, ALT, AST, and bilirubin. None of the three discussed here is included. Each must be ordered separately or as part of an expanded panel — which is the central reason they remain underused in routine functional assessment.

Why is GGT considered an oxidative stress marker rather than just a liver enzyme?

Because GGT participates directly in glutathione metabolism at the cell membrane, its serum activity rises as the body works to maintain antioxidant balance — often before any structural liver injury exists. An elevated GGT with otherwise normal liver enzymes typically reflects systemic oxidative stress and toxin or medication burden, and it independently predicts cardiovascular and all- cause mortality, which places it well beyond a simple hepatobiliary marker.

How does uric acid relate to insulin resistance?

Fructose metabolism generates uric acid as a byproduct, and elevated uric acid reduces endothelial nitric oxide — a mediator of insulin's action — which impairs glucose uptake into skeletal muscle and promotes insulin resistance. It also drives mitochondrial oxidative stress and adipose inflammation. This is why uric acid frequently rises years before fasting glucose, making it an early metabolic signal rather than only a gout marker.

What is the most useful application of LDH in functional practice?

Detecting hemolysis. Because red blood cells contain LDH, their breakdown raises serum LDH, and the triad of elevated LDH, low haptoglobin, and elevated indirect bilirubin identifies hemolysis specifically. This matters because undetected hemolysis distorts ferritin, iron studies, and bilirubin — so catching it reframes the entire panel. LDH also flags general tissue turnover, and a significant unexplained elevation warrants investigation and, when persistent, referral.

When should I add all three to a client's order?

An initial comprehensive workup is the natural place — the three together cost little and add oxidative, metabolic, and cellular dimensions the CMP omits. They become especially valuable when the clinical picture includes fatigue, suspected toxic or mold exposure, unexplained anemia, or metabolic patterns that aren't fully explained by the standard markers.